Specific immunotherapy and cellular immunity in patients with cervical cancer-Reference-Cited by-同舟云学术

Specific immunotherapy and cellular immunity in patients with cervical cancer

Published:2013-06-15 Issue:3 Volume:18 Page:42-45
ISSN:2412-9119
Container-title:Russian Journal of Oncology
language:
Short-container-title:Russian Journal of Oncology

Author:

Lazarev A. F.,Kenbayeva D. K.,Manambayeva Z. A.

Abstract

The influence of a combination antineoplastic and immunotherapies on a condition of a cellular immunity in patients with cervical cancer of stage I-IIA is defined. Decrease in indicators of immunity system in the surveyed patients and moderate dynamics of their increase is revealed during the treatment, not being accompanied by adequate restoration of killer cells number.

Publisher

ECO-Vector LLC

Subject

General Medicine

Reference9 articles.

1. Лыков А.П., Басс А.А., Морозов Д.В., Абрамов В.В. и др. Аденокарцинома желудка: клинико-иммунологические особенности. Вопросы онкологии. 2003; 1: 41-3.

2. Маринова-Мутафчиева Л.П., Чакалова Г.Б., Горанов И.Т. Супрессия клеточного иммунитета у больного с карциномой in situ и микроинвазивным раком шейки матки. Вопросы онкологии. 1997; 37(4): 454-6.

3. Camus M., Galon J. Memory T-cell responses and survival in human cancer: remember to stay alive. Adv. Exp. Med. Biol. 2010; 684: 166-77.

4. Osada J., Kamocki Z., Rusak M. et al. The effect of surgical and nutritional treatment on activation parameters of peripheral blood T lymphocytes in stomach cancer patients in postoperative period. Pol. Merkur. Lek. 2008; 24(141): 231-6.

5. Гранов А.М., Винокуров В.Л. Лучевая терапия в онкогинекологии и онкоурологии. СПб.: Фолиант; 2002.